CVE-2022-24043

Description

A vulnerability has been identified in Desigo DXR2 (All versions < V01.21.142.5-22), Desigo PXC3 (All versions < V01.21.142.4-18), Desigo PXC4 (All versions < V02.20.142.10-10884), Desigo PXC5 (All versions < V02.20.142.10-10884). The login functionality of the application fails to normalize the response times of login attempts performed with wrong usernames with the ones executed with correct usernames. A remote unauthenticated attacker could exploit this side-channel information to perform a username enumeration attack and identify valid usernames.

Category

5.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.57%
Vendor Advisory siemens.com
Affected: Siemens Desigo DXR2
Affected: Siemens Desigo PXC3
Affected: Siemens Desigo PXC4
Affected: Siemens Desigo PXC5
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-24043?
CVE-2022-24043 has been scored as a medium severity vulnerability.
How to fix CVE-2022-24043?
To fix CVE-2022-24043, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-24043 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-24043 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-24043?
CVE-2022-24043 affects Siemens Desigo DXR2, Siemens Desigo PXC3, Siemens Desigo PXC4, Siemens Desigo PXC5.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.